Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Maxim Group Downgrades Pulse Biosciences to Hold

Maxim Group Downgrades Pulse Biosciences to Hold

Maxim Group analyst Anthony Vendetti downgrades Pulse Biosciences (NASDAQ:PLSE) from Buy to Hold.

byBenzinga Newsdesk

September 21, 2022

1 minute read

Maxim Group analyst Anthony Vendetti downgrades Pulse Biosciences (NASDAQ:PLSE) from Buy to Hold.

JP Morgan Downgrades Under Armour to Neutral, Lowers Price Target to $10

By Benzinga Newsdesk

March 13, 6:03 AM

JP Morgan analyst Matthew Boss downgrades Under Armour (NYSE:UAA) from Overweight to Neutral and lowers the price target from $13 to $10.

News

Synopsys, Ansys And Keysight Collaborate With TSMC To Boost Performance Of Autonomous Systems With New mmWave Reference Flow

By Happy Mohamed

April 26, 8:17 AM

79-GHz mmWave RF Design Flow for TSMC 16FFC Accelerates Development of Radio-Frequency ICs Used in Autonomous Systems MOUNTAIN VIEW, Calif., April 26, 2023 /PRNewswire/ -- To accelerate development of

ANSS

Analyst Ratings

Where Mobileye Global Stands With Analysts

By Benzinga Insights

July 25, 1:00 PM

Over the past 3 months, 16 analysts have published their opinion on Mobileye Global (NASDAQ:MBLY) stock. These analysts…

MBLY

Keybanc Maintains Overweight on ITT, Lowers Price Target to $90

By Benzinga Newsdesk

July 12, 4:51 AM

Keybanc analyst Todd Thomas maintains ITT (NYSE:ITT) with a Overweight and lowers the price target from $100 to $90.

ITT

Maxim Group Downgrades Pulse Biosciences to Hold

Related Posts

JP Morgan Downgrades Under Armour to Neutral, Lowers Price Target to $10

Synopsys, Ansys And Keysight Collaborate With TSMC To Boost Performance Of Autonomous Systems With New mmWave Reference Flow

Where Mobileye Global Stands With Analysts

Keybanc Maintains Overweight on ITT, Lowers Price Target to $90